These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 26330436)

  • 1. Intensive Care Nurses' Knowledge About Use of Neuromuscular Blocking Agents in Patients With Respiratory Failure.
    Frazee EN; Personett HA; Bauer SR; Dzierba AL; Stollings JL; Ryder LP; Elmer JL; Caples SM; Daniels CE
    Am J Crit Care; 2015 Sep; 24(5):431-9. PubMed ID: 26330436
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceived safety and efficacy of neuromuscular blockers for acute respiratory distress syndrome among medical intensive care unit practitioners: A multicenter survey.
    Torbic H; Bauer SR; Personett HA; Dzierba AL; Stollings JL; Ryder LP; Daniels CE; Caples SM; Frazee EN
    J Crit Care; 2017 Apr; 38():278-283. PubMed ID: 28012426
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Current therapeutic uses, pharmacology, and clinical considerations of neuromuscular blocking agents for critically ill adults.
    Warr J; Thiboutot Z; Rose L; Mehta S; Burry LD
    Ann Pharmacother; 2011 Sep; 45(9):1116-26. PubMed ID: 21828347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To Block or Not: Updates in Neuromuscular Blockade in Acute Respiratory Distress Syndrome.
    Mefford B; Donaldson JC; Bissell BD
    Ann Pharmacother; 2020 Sep; 54(9):899-906. PubMed ID: 32111121
    [No Abstract]   [Full Text] [Related]  

  • 5. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A national survey of critical care nurses' practices related to administration of neuromuscular blocking agents.
    Foster JG; Kish SK; Keenan CH
    Am J Crit Care; 2001 May; 10(3):139-45. PubMed ID: 11340735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monitoring neuromuscular blockade in the intensive care unit: the peripheral nerve stimulator.
    Rowlee SC
    Heart Lung; 1999; 28(5):352-62; quiz 363-4. PubMed ID: 10486453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Applied pharmacology of common neuromuscular blocking agents in critical care.
    Prielipp RC; Coursin DB
    New Horiz; 1994 Feb; 2(1):34-47. PubMed ID: 7922428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paralytics in critical care: not always the bad guy.
    Forel JM; Roch A; Papazian L
    Curr Opin Crit Care; 2009 Feb; 15(1):59-66. PubMed ID: 19186410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuromuscular blocking agents decrease inflammatory response in patients presenting with acute respiratory distress syndrome.
    Forel JM; Roch A; Marin V; Michelet P; Demory D; Blache JL; Perrin G; Gainnier M; Bongrand P; Papazian L
    Crit Care Med; 2006 Nov; 34(11):2749-57. PubMed ID: 16932229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. National practice with assessment and monitoring of neuromuscular blockade.
    Foster JG; Kish SK; Keenan CH
    Crit Care Nurs Q; 2002 Aug; 25(2):27-40. PubMed ID: 12211334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of neuromuscular blockers in ARDS: benefits and risks.
    Hraiech S; Forel JM; Papazian L
    Curr Opin Crit Care; 2012 Oct; 18(5):495-502. PubMed ID: 22941207
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of sedatives, opioids, and neuromuscular blocking agents in patients with acute lung injury and acute respiratory distress syndrome.
    Arroliga AC; Thompson BT; Ancukiewicz M; Gonzales JP; Guntupalli KK; Park PK; Wiedemann HP; Anzueto A;
    Crit Care Med; 2008 Apr; 36(4):1083-8. PubMed ID: 18401254
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular blocking agents for acute respiratory distress syndrome: an updated meta-analysis of randomized controlled trials.
    Zheng Z; Jiang L; Zhang S; Guervilly C; Zhang M; Feng X; Ding J
    Respir Res; 2020 Jan; 21(1):23. PubMed ID: 31931794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a policy for patients receiving neuromuscular blocking agents.
    Earl G; McMahon MB; Bartley M; Mancini W; Becker S
    J Trauma Nurs; 1997; 4(3):76-81. PubMed ID: 9407819
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacoeconomic issues of sedation, analgesia, and neuromuscular blockade in critical care.
    Armstrong DK; Crisp CB
    New Horiz; 1994 Feb; 2(1):85-93. PubMed ID: 7922434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiopulmonary implications of neuromuscular blockade.
    Sandmeyer NP; Ashworth LJ
    Crit Care Nurs Q; 1995 Aug; 18(2):25-40. PubMed ID: 7621094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of paralytics in patients with acute respiratory distress syndrome.
    Hraiech S; Dizier S; Papazian L
    Clin Chest Med; 2014 Dec; 35(4):753-63. PubMed ID: 25453423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Continuous-infusion neuromuscular blocking agents in critically ill neonates and children.
    Johnson PN; Miller J; Gormley AK
    Pharmacotherapy; 2011 Jun; 31(6):609-20. PubMed ID: 21923445
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey of the use of sedating drugs, neuromuscular blocking agents, and reversal agents in the intensive care unit.
    Rhoney DH; Murry KR
    J Intensive Care Med; 2003; 18(3):139-45. PubMed ID: 14984632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.